Cartesian Therapeutics, Inc. (RNAC) Tops Q2 EPS by 144c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: RNAC) | Delayed: 6.18 -0.23 (3.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.41 | 52 Week High | $ | |||
| Open | $6.38 | 52 Week Low | $ | |||
| Day High | $6.52 | P/E | N/A | |||
| Day Low | $6.11 | EPS | $ | |||
| Volume | 85,902 | |||||
